← Product Code [EAM](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/EAM) · K920190

# ULTRA-VISION RAPID INTENSIFYING SCREEN (K920190)

_E.I. Dupont DE Nemours & Co., Inc. · EAM · May 28, 1992 · Radiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/EAM/K920190

## Device Facts

- **Applicant:** E.I. Dupont DE Nemours & Co., Inc.
- **Product Code:** [EAM](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/EAM.md)
- **Decision Date:** May 28, 1992
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 892.1960
- **Device Class:** Class 1
- **Review Panel:** Radiology

## Regulatory Identification

A radiographic intensifying screen is a device that is a thin radiolucent sheet coated with a luminescent material that transforms incident x-ray photons into visible light and intended for medical purposes to expose radiographic film.

---

**Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/EAM/K920190](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/EAM/K920190)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com